HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
N(6)-phenyl-N(6)-allyladenosine
Also Known As:
BM 11,189; BM 11189; BM-11189; Adenosine, N-phenyl-N-2-propenyl-
Networked:
1
relevant articles (
0
outcomes,
0
trials/studies)
Bio-Agent Context: Research Results
Heterocyclic Compounds: 198
Fused-Ring Heterocyclic Compounds
2-Ring Heterocyclic Compounds
Purines: 651
Purine Nucleosides: 360
Adenosine: 12431
N(6)-phenyl-N(6)-allyladenosine: 1
Nucleic Acids, Nucleotides, and Nucleosides: 1
Nucleosides: 6847
Purine Nucleosides: 360
Adenosine: 12431
N(6)-phenyl-N(6)-allyladenosine: 1
Ribonucleosides: 49
Adenosine: 12431
N(6)-phenyl-N(6)-allyladenosine: 1
Related Diseases
1.
Coronary Occlusion
10/01/1987 - "
The effect of N(6)-phenyl-N(6)-allyladenosine (PAA, BM 11.189) on myocardial ischemic stress was evaluated in six open-chest mongrel dogs during repeated coronary occlusions of 3 min. Whereas there was not significant change in hemodynamic parameters before and during coronary occlusions after treatment, PAA reduced significantly epicardial ST-segment elevations (-34%) during ischemia and myocardial release of lactate (-43%), phosphate (-44%), and potassium (-48%) in the early reperfusion period.
"
2.
Ischemia
10/01/1987 - "
The effect of N(6)-phenyl-N(6)-allyladenosine (PAA, BM 11.189) on myocardial ischemic stress was evaluated in six open-chest mongrel dogs during repeated coronary occlusions of 3 min. Whereas there was not significant change in hemodynamic parameters before and during coronary occlusions after treatment, PAA reduced significantly epicardial ST-segment elevations (-34%) during ischemia and myocardial release of lactate (-43%), phosphate (-44%), and potassium (-48%) in the early reperfusion period.
"
Related Drugs and Biologics
1.
Lactic Acid (Lactate)
2.
Potassium
3.
Phosphates (Orthophosphate)
Related Therapies and Procedures
1.
Aftercare (After-Treatment)